ESIO-Update 2025 - Microbiome and Immunology скачать в хорошем качестве

ESIO-Update 2025 - Microbiome and Immunology

Lecture “Microbiome and Immunology” by Dr. med. Alix Schwarz, TUM University Hospital rechts der Isar, Munich at the ESIO Update 2025 on the topic “Immunotherapy and integrative Oncology”. ▬ With the kind support of ▬▬ Galexis: https://www.galexis.com/de/ cannaplant: https://cannaplant.ch/geschichte/ Laborgemeinschaft LG1: http://www.lg1.ch Helixor: https://www.helixor.de Pfizer Oncology: https://www.pfizer.com/ Iscador: https://iscador.com/ Gilead: https://www.gileadsciences.de/ Sandoz: https://www.sandoz.de/ accord: https://www.accord-healthcare.com/ Abnoba Viscum: https://www.abnoba.de/mistletoe-thera... andromedic: https://andromedic.eu/ ▬Thanks also to our partners▬▬ ZIO AG: https://integrative-onkologie.ch Spital Zollikerberg: https://spitalzollikerberg.ch/ Kantonsspital St. Gallen: https://www.kssg.ch ▬ About ESIO ▬▬▬▬▬▬▬▬▬▬▬▬▬ The “European Society for Integrative Oncology” sees itself as a forum for the promotion of complementary and experiential therapies in oncology. We want to inform therapists as well as patients and their relatives about appropriate treatment options, intensify cooperation between different therapeutic approaches and, last but not least, reduce reservations by supporting clinical research projects. What do we mean by integrative oncology? Integrative oncology is medicine that is characterized by a mindful, respectful attitude that promotes the autonomy and resources of the patient and sensibly combines specific cancer therapy with supportive and complementary medical therapy methods. The implementation of integrative oncology is scientifically sound, transparent and tailored to the needs of the patient.